Table 3. Association between the incidence of acute respiratory failure for different levels of average frequency of hospital and clinical visits for PM/DM and estimation of the risk of respiratory failure using multivariate Cox proportional hazards regression analysis.
| Average frequency of PM/DM, per year | Event | PYs | Rate | Crude HR (95% CI) | Adjusted HR (95% CI) |
|---|---|---|---|---|---|
| Non-PM/DM cohort | 335 | 90,336 | 37.08 | Ref | Ref |
| PM/DM cohort | |||||
| <8 | 18 | 2,609 | 68.99 | 1.86 (1.16–2.99) | 1.78 (1.10–2.90) |
| 8–15 | 37 | 3,216 | 115.05 | 3.09 (2.20–4.34) | 2.59 (1.81–3.70) |
| ≥16 | 116 | 1,627 | 712.97 | 18.57 (15.00–22.98) | 12.2 (9.58–15.50) |
Model adjusted for age, sex, CCI score, asthma, hypertension, diabetes, COPD, pneumonia, cancer, CAD, heart failure, and PVD, and medicine of oral steroid. PM/DM, polymyositis/dermatomyositis; rate, per 10000 person-years; PYs, person-years; CI, confidence interval; HR, hazard ratio; CCI score, Charlson comorbidity index score; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; PVD, pulmonary vascular disease.